Announcement| Volume 43, ISSUE 4, PIII-IV, April 2017

Download started.



        MD Anderson Madrid Cancer Fellowship

        The 2017 call for applications for the exclusive MD Anderson Cancer Fellowship for Associate Clinical Investigators is open.
        This Fellowship Programme will start in June 2017, and it includes a stay of 12-24 months at MD Anderson Cancer Center Houston. Thanks to this opportunity, fellows will receive a highly-specialized training in different areas of cancer research, both clinical and translational.
        Fellowships candidates are specialists in medical oncology, haematology, radiation oncology, and surgical oncology, who completed their specialized training (MIR) in the past three years. They must propose a training program associated with a research project related with the priority areas of the call: investigational cancer therapeutics (phase i clinical trials programme) and personalized advanced cancer therapy.
        More information:

        EJSO Digital version

        ESSO, BASO and Elsevier are happy to offer a digital version of the European Journal of Surgical Oncology (EJSO).
        ESSO members can now view the digital Journal from the members’ area of the ESSO website.
        We hope that you enjoy using this new member benefit!
        You can login to your membership profile using the link
        If you do not remember your login or password use the forgot your login/password button or contact the ESSO secretariat at [email protected]

        GO SAFE Project: Better Understanding Outcomes in Elderly Patients

        GO SAFE (Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery) is a new research study that will evaluate postoperative functional outcomes and quality of life after cancer surgery in geriatric patients.
        Promoted by ESSO (the European Society of Surgical Oncology) and the surgical task force of SIOG (International Society of Geriatric Oncology), GO SAFE was recently launched under the lead of the Chief Investigator Prof. Giampaolo Ugolini (Bologna, Italy) as well as several ESSO experts – including the immediate Past President Prof. Riccardo Audisio (Liverpool, UK).
        GO SAFE is an international high-quality registry, which will address this problem and prospectively investigate how frailty, comorbidities and malnourishment are associated with clinical outcomes after surgery for solid malignancies in this patient population. The study will involve units from various countries that perform cancer surgery in elderly cancer patients. In particular, it will focus on patients’ quality of life and functional recovery, comparing the pre- and postoperative situation through a self-reported assessment tool.
        The findings of GO SAFE will assist clinicians in assessing patients as well as in tailoring their care, avoiding under/overtreatment and identifying new strategies to improve functional outcomes. Its final objective is to ensure as much as possible a satisfactory quality of life after treatment as well as the conservation of independence to onco-geriatric patients.
        For more information about GO SAFE, visit

        CORSiCA: Investigating Rectal Cancer’s Nodal Positivity Before Surgery

        Conceived in the framework of the EYSAC young researchers' activities, the proposal for the project CORSiCA ‘Complete pathologic response rectal cancers EYSAC.1 Study’ will investigate complete responders’ rectal cancers at the European level.
        About 20% of patients with rectal cancers who received neoadjuvant treatment achieve a pathological complete response in the surgical specimen (ypT0). However, about 10% of ypT0 present metastatic nodes and, thus, the identification of surgical specimen with metastatic nodes could be crucial in order to tailor future treatments and improve their chances of cure.
        Once accepted, the CORSiCA project will build a large database with the clinical, pathological and radiological data of pathologic complete responders, to study ypT0 rectal cancers in relation to the nodal status and, thus, predict the nodal positivity before surgical treatment.
        The CORSiCA proposal is currently under review by the European Research Council (ERC) as a ‘starting grant project’. After having conducted at the Italian level a retrospective multicentric study on 230 ypT0 focused on treatment and outcomes, the Research Delegate of the ESSO Young Surgeons and Alumni Club (EYSAC) Steering Committee Dr. Laura Lorenzon (Sapienza University of Rome, Italy) will be the Principal Investigator of this new project.
        ESSO will be a project partner in CORSiCA, thanks to the precious project contribution of Prof. Geerard Beets from the ESSO Education Committee (Netherlands Cancer Institute, Amsterdam), President of the Italian Society of Surgical Oncology Prof. Paolo Delrio (National Cancer Institute “Pascale Foundation”, Naples) and EYSAC Chair Dr. Karol Polom (Poland/Italy).
        An overview of the CORSiCA project is available from the ESSO website at

        Memorandum of Understanding between ESSO and the Korean Society of Surgical Oncology

        The SISSO Congress (Seoul International Symposium of Surgical Oncology) was the opportunity to formalize the ESSO affiliated membership of the Korean Society of Surgical Oncology (KSSO) in a MoU signing ceremony in presence of the ESSO President, Professor Santiago Gonzalez-Moreno, and President-Elect, Dr. Tibor Kovacs.